TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.

Adi Diab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.